Company AVAX Technologies, Inc. Other OTC
Equities
AVXT
US0534953056
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -15.98% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -15.98% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Adele Sommerfeld
CEO | Chief Executive Officer | - | 15-10-18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew W. Dahl
CHM | Chairman | 79 | 99-08-31 |
Adele Sommerfeld
CEO | Chief Executive Officer | - | 15-10-18 |
Bruno Maruzzo
BRD | Director/Board Member | 71 | - |
Serge Morrell
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 142,605,753 | 142,605,753 ( 100.00 %) | 0 | 100.00 % |
Company contact information
AVAX Technologies, Inc.
2000 Hamilton Street Suite 204
19130, Philadelphia
+
Sector
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |